Article By:
NASDAQ GlobeNewswire
Friday, September 23, 2016 3:40 PM EST
Aquinox Pharmaceuticals, Inc. today announced the closing of its previously announced underwritten public offering of 6,152,500 shares of its common stock, including 802,500 shares sold pursuant to the underwriters.